United Pharma Technologies Inc · 4 days ago
Commissioning & Qualification Engineer
United Pharma Technologies Inc is a pharmaceutical manufacturing company seeking an experienced Commissioning & Qualification Engineer to support Utilities Commissioning & Qualification activities. The role involves authoring and executing test cases, participating in plant startup, and providing field support during test execution.
Responsibilities
Support Utilities C&Q activities in a GMP pharmaceutical environment
Participate in API plant startup and shakedown
Author and execute Commissioning and Qualification test cases
Create generic test templates for use across multiple utility systems
Assist with preparation of System Startup, Shakedown, and OV test documents
Review and complete documentation based on FSs, TMs, and CLIAs
Drive document reviews, updates, and approvals
Provide field support during test execution
Act as a Utilities team liaison for Automation-related coordination
Qualification
Required
10–15 years of Pharmaceutical C&Q experience (mandatory)
Strong background in Utilities C&Q
Experience with DeltaV systems (interaction/support level)
Experience supporting API manufacturing facilities
Proven expertise writing C&Q test cases, CLIAs, TMs, and FSs
Solid understanding of GMP and regulatory requirements
Ability to work independently in a fast-paced onsite environment
Company
United Pharma Technologies Inc
United Pharma Technologies (UPT) is a global life-science services company delivering CQV, validation, quality, automation, and regulatory compliance solutions to the pharmaceutical, biotechnology, medical device, and diagnostics sectors.
H1B Sponsorship
United Pharma Technologies Inc has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (50)
2024 (81)
2023 (77)
2022 (69)
2021 (46)
2020 (57)
Funding
Current Stage
Growth StageTotal Funding
unknown2022-07-18Acquired
Company data provided by crunchbase